Group 1 - The company, Jingyan Technology (300709.SZ), has disclosed a plan to issue convertible bonds to unspecified investors, with a total fundraising amount not exceeding 578 million yuan (including principal) [1] - The initial conversion price of the bonds will not be lower than the average trading price of the company's stock over the twenty trading days prior to the announcement of the fundraising prospectus and the trading price on the previous trading day [1] - After deducting issuance costs, the net proceeds from the fundraising are intended to be invested in projects related to the production of precision MIM components and assemblies for new consumer electronics and data servers, as well as the construction of a headquarters and R&D center, and a precision mold center [1]

奥士康(002913.SZ)公告称，拟发行可转债募资不超过10亿元，用于高端印制电路板项目。 ...

Core Viewpoint - Jiangsu Leili plans to issue convertible bonds to raise up to 1.286 billion yuan for various production and development projects, enhancing its core competitiveness in the micro-motor and intelligent component manufacturing industry [1][2][4]. Fundraising and Investment Projects - The company aims to use the raised funds for projects including the production of laser radar motors, laser equipment galvanometer systems, automotive micro-motors, and components, as well as the establishment of a robotics control component R&D center and overseas production bases [2][3]. - The total investment for the "intelligent sensing laser radar and vehicle thermal management micro-motor, laser equipment galvanometer system production project" is planned at 229 million yuan, with 219 million yuan from the raised funds [2]. - The "automotive micro-motor and component production base and laboratory construction project" has a total investment of 287 million yuan, with 277 million yuan expected from the fundraising [2]. Overseas Expansion and Market Coverage - Jiangsu Leili plans to enhance its overseas presence to meet the growing international market demand, with investments in production bases in Malaysia, Vietnam, and Mexico totaling 440 million yuan, of which 410 million yuan will come from the raised funds [3]. - The company’s revenue distribution shows 53.35% from domestic markets and 46.65% from international markets for the 2024 fiscal year [3]. Financial Performance and Growth Strategy - In Q1 2025, Jiangsu Leili reported a revenue of 908 million yuan, a year-on-year increase of 25.81%, and a net profit attributable to shareholders of 94 million yuan, up 28.15% [1][7]. - The company aims for a sales target of 4.1 billion yuan for 2025, representing a 16.5% year-on-year growth [7]. R&D and Innovation - Jiangsu Leili has consistently increased its R&D investment, with amounts of 133 million yuan, 147 million yuan, and 168 million yuan from 2022 to 2024, maintaining a stable R&D expenditure ratio of around 4.77% of revenue [6]. - The company has expanded its product applications from home appliances to sectors such as new energy, medical devices, and industrial control through strategic acquisitions [5][6]. Dividend Policy - Since its listing, Jiangsu Leili has distributed a total of 960 million yuan in cash dividends, representing 47% of its cumulative net profit during this period [5][7].

Core Viewpoint - Lepu Medical reported a significant decline in financial performance for the year 2024, with a notable drop in revenue and net profit compared to the previous year [1][2]. Financial Performance Summary - The company's operating revenue for 2024 was 6.10 billion yuan, a decrease of 23.52% from 2023's 7.98 billion yuan [2]. - Net profit attributable to shareholders was 246.94 million yuan, down 80.37% from 1.26 billion yuan in 2023 [2]. - The net profit after deducting non-recurring gains and losses was 221.43 million yuan, reflecting an 80.28% decline from 1.12 billion yuan in the previous year [2]. - The net cash flow from operating activities was 734.64 million yuan, a decrease of 25.82% compared to 990.36 million yuan in 2023 [2]. Historical Comparison - In 2023, Lepu Medical's operating revenue was 7.98 billion yuan, down 24.78% from 2022 [3]. - The net profit attributable to shareholders in 2023 was 1.26 billion yuan, a decrease of 42.91% from 2022 [3]. - The net cash flow from operating activities in 2023 was 990.36 million yuan, down 64.51% from 2022 [3]. Profit Distribution Plan - The company approved a profit distribution plan, proposing a cash dividend of 1.35 yuan per 10 shares (including tax) to all shareholders, with no bonus shares [2].

制图：佘诗婕 星标 ★ IPO日报 精彩文章第一时间推送 据IPO日报汇总，3月24日至3月30日，即上周一周内，多家上市公司发布发行可转债募资公告。其中，3月28日，三友化工（600409.SH）拟公开发 行公司债券，规模不超过9亿元，美力科技（300611.SZ）拟发行可转债募资不超过3亿元。 另外，3月28日，上交所和深交所修订并发布了《上海证券交易所公司债券发行上市审核规则适用指引第3号——审核重点关注事项（2025年修订）》、 《深圳证券交易所公司债券发行上市审核业务指引第2号——审核重点关注事项（2025年修订）》，旨在进一步强化公司债券（含企业债券）发行准入监 管，提升审核透明度，推动市场高质量发展。 3月24日至3月30日发债情况汇总 制图：李昕 三家5年内多次募资 上周，多家上市公司发布公告，拟通过发行可转换债券募资，涵盖新能源汽车、跨境电商、机器人等领域，IPO日报整理发现，无锡振华 （605319.SH）、瑞鹄模具（002997.SZ）和双乐股份（301036.SZ）均为上市5年内多次募资。目前无锡振华发行可转债申请获上交所通过。 3月26日，无锡振华公告称，公司向不特定对象发行可转换公 ...